The Global Urometer Market was valued at USD 575.2 million in 2025 and is estimated to grow at a CAGR of 7.9% to reach USD 1.2 billion by 2035.
This expansion is supported by the growing incidence of urological conditions, a higher number of surgical procedures, and increasing admissions in critical care settings. In addition, the expanding elderly population is contributing significantly to demand, as aging individuals are more prone to conditions requiring continuous monitoring of urinary output. The adoption of stringent infection prevention protocols across healthcare facilities is further strengthening the use of advanced monitoring devices. A urometer is a specialized medical device used to measure and track urine output accurately over a specified period, typically integrated within a closed drainage system connected to a catheter and collection unit. Changing lifestyles and the growing burden of chronic diseases are also increasing the need for efficient monitoring systems, reinforcing the importance of urometers in both acute and long-term care environments.
The 500 ml segment generated USD 200.2 million in 2025. This segment’s strong position is supported by its widespread use in clinical environments where continuous and precise monitoring is required. Its balanced design allows for effective measurement over extended durations, making it suitable for adult patient care. The ability to support consistent monitoring needs in high-dependency settings has contributed significantly to its dominance.
The disposable segment accounted for 82.4% share in 2025, driven by its operational efficiency and strong infection control benefits. Single-use devices eliminate the need for cleaning and sterilization, reducing time, labor, and resource requirements. These advantages make them highly suitable for fast-paced healthcare environments where maintaining hygiene standards and minimizing turnaround time are essential. Additionally, predictable cost structures associated with disposable products further support their widespread adoption.
United States Urometer Market was valued at USD 213.7 million in 2025, supported by a well-developed healthcare ecosystem and strong clinical adoption. Healthcare professionals across the country consistently rely on urometers in various care settings to ensure accurate monitoring of patient conditions. Established clinical protocols and increasing awareness of patient safety are contributing to sustained demand. Furthermore, the growing burden of chronic health conditions is reinforcing the need for precise and continuous monitoring, supporting ongoing market expansion.
Key companies operating in the Global Urometer Market include Becton, Dickinson and Company, B. Braun, Cardinal Health, Teleflex, Convatec, Medline, Laborie, Romsons Group, Sterimed Group, Advin Health Care, ANGIPLAST, Fannin, Forlong Medical, Hitec Medical, and Observe Medical. Companies in the Urometer Market are strengthening their competitive position through product innovation, strategic partnerships, and expansion of distribution networks. They are investing in advanced designs that improve measurement accuracy, ease of use, and patient safety. Many players are focusing on developing cost-effective disposable solutions to meet the rising demand for infection control. Collaborations with healthcare providers and institutions are helping expand market reach and improve product adoption. In addition, companies are enhancing their global presence by entering emerging markets and strengthening supply chain capabilities.
This product will be delivered within 2-4 business days.
This expansion is supported by the growing incidence of urological conditions, a higher number of surgical procedures, and increasing admissions in critical care settings. In addition, the expanding elderly population is contributing significantly to demand, as aging individuals are more prone to conditions requiring continuous monitoring of urinary output. The adoption of stringent infection prevention protocols across healthcare facilities is further strengthening the use of advanced monitoring devices. A urometer is a specialized medical device used to measure and track urine output accurately over a specified period, typically integrated within a closed drainage system connected to a catheter and collection unit. Changing lifestyles and the growing burden of chronic diseases are also increasing the need for efficient monitoring systems, reinforcing the importance of urometers in both acute and long-term care environments.
The 500 ml segment generated USD 200.2 million in 2025. This segment’s strong position is supported by its widespread use in clinical environments where continuous and precise monitoring is required. Its balanced design allows for effective measurement over extended durations, making it suitable for adult patient care. The ability to support consistent monitoring needs in high-dependency settings has contributed significantly to its dominance.
The disposable segment accounted for 82.4% share in 2025, driven by its operational efficiency and strong infection control benefits. Single-use devices eliminate the need for cleaning and sterilization, reducing time, labor, and resource requirements. These advantages make them highly suitable for fast-paced healthcare environments where maintaining hygiene standards and minimizing turnaround time are essential. Additionally, predictable cost structures associated with disposable products further support their widespread adoption.
United States Urometer Market was valued at USD 213.7 million in 2025, supported by a well-developed healthcare ecosystem and strong clinical adoption. Healthcare professionals across the country consistently rely on urometers in various care settings to ensure accurate monitoring of patient conditions. Established clinical protocols and increasing awareness of patient safety are contributing to sustained demand. Furthermore, the growing burden of chronic health conditions is reinforcing the need for precise and continuous monitoring, supporting ongoing market expansion.
Key companies operating in the Global Urometer Market include Becton, Dickinson and Company, B. Braun, Cardinal Health, Teleflex, Convatec, Medline, Laborie, Romsons Group, Sterimed Group, Advin Health Care, ANGIPLAST, Fannin, Forlong Medical, Hitec Medical, and Observe Medical. Companies in the Urometer Market are strengthening their competitive position through product innovation, strategic partnerships, and expansion of distribution networks. They are investing in advanced designs that improve measurement accuracy, ease of use, and patient safety. Many players are focusing on developing cost-effective disposable solutions to meet the rising demand for infection control. Collaborations with healthcare providers and institutions are helping expand market reach and improve product adoption. In addition, companies are enhancing their global presence by entering emerging markets and strengthening supply chain capabilities.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Product, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Usability, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Application, 2022-2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 10 Company Profiles
Companies Mentioned
The companies profiled in this Urometer market report include:- Advin Health Care
- ANGIPLAST
- B. Braun
- Becton, Dickinson and Company
- Cardinal Health
- Convatec
- Fannin
- Forlong Medical
- Hitec Medical
- Laborie
- Medline
- Observe Medical
- Romsons Group
- Sterimed Group
- Teleflex
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | April 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 575.2 Million |
| Forecasted Market Value ( USD | $ 1200 Million |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
